nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Neuralgia—Docetaxel—head and neck cancer	0.00623	0.00623	CcSEcCtD
Sibutramine—Inflammation—Fluorouracil—head and neck cancer	0.00619	0.00619	CcSEcCtD
Sibutramine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00593	0.00593	CcSEcCtD
Sibutramine—Face oedema—Hydroxyurea—head and neck cancer	0.00584	0.00584	CcSEcCtD
Sibutramine—Neuritis—Docetaxel—head and neck cancer	0.0058	0.0058	CcSEcCtD
Sibutramine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00567	0.00567	CcSEcCtD
Sibutramine—Angina pectoris—Vinblastine—head and neck cancer	0.00559	0.00559	CcSEcCtD
Sibutramine—Otitis media—Docetaxel—head and neck cancer	0.00556	0.00556	CcSEcCtD
Sibutramine—Oesophagitis—Fluorouracil—head and neck cancer	0.00548	0.00548	CcSEcCtD
Sibutramine—Sepsis—Fluorouracil—head and neck cancer	0.00521	0.00521	CcSEcCtD
Sibutramine—Euphoric mood—Fluorouracil—head and neck cancer	0.00516	0.00516	CcSEcCtD
Sibutramine—Depression—Vinblastine—head and neck cancer	0.0051	0.0051	CcSEcCtD
Sibutramine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00504	0.00504	CcSEcCtD
Sibutramine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00501	0.00501	CcSEcCtD
Sibutramine—Myocardial infarction—Vinblastine—head and neck cancer	0.00501	0.00501	CcSEcCtD
Sibutramine—Photosensitivity—Fluorouracil—head and neck cancer	0.00496	0.00496	CcSEcCtD
Sibutramine—Amenorrhoea—Docetaxel—head and neck cancer	0.00493	0.00493	CcSEcCtD
Sibutramine—Chest discomfort—Docetaxel—head and neck cancer	0.0049	0.0049	CcSEcCtD
Sibutramine—Dysuria—Hydroxyurea—head and neck cancer	0.00489	0.00489	CcSEcCtD
Sibutramine—Bone disorder—Docetaxel—head and neck cancer	0.0048	0.0048	CcSEcCtD
Sibutramine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00476	0.00476	CcSEcCtD
Sibutramine—Weight increased—Hydroxyurea—head and neck cancer	0.00476	0.00476	CcSEcCtD
Sibutramine—Amnesia—Fluorouracil—head and neck cancer	0.00464	0.00464	CcSEcCtD
Sibutramine—Haemoglobin—Vinblastine—head and neck cancer	0.00461	0.00461	CcSEcCtD
Sibutramine—Haemorrhage—Vinblastine—head and neck cancer	0.00459	0.00459	CcSEcCtD
Sibutramine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00457	0.00457	CcSEcCtD
Sibutramine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00457	0.00457	CcSEcCtD
Sibutramine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00456	0.00456	CcSEcCtD
Sibutramine—Pharyngitis—Vinblastine—head and neck cancer	0.00456	0.00456	CcSEcCtD
Sibutramine—Stomatitis—Hydroxyurea—head and neck cancer	0.00455	0.00455	CcSEcCtD
Sibutramine—Bone pain—Docetaxel—head and neck cancer	0.00452	0.00452	CcSEcCtD
Sibutramine—Inflammation—Docetaxel—head and neck cancer	0.00447	0.00447	CcSEcCtD
Sibutramine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00436	0.00436	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00436	0.00436	CcSEcCtD
Sibutramine—Blood pressure increased—Docetaxel—head and neck cancer	0.00433	0.00433	CcSEcCtD
Sibutramine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00433	0.00433	CcSEcCtD
Sibutramine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00421	0.00421	CcSEcCtD
Sibutramine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00419	0.00419	CcSEcCtD
Sibutramine—Colitis—Docetaxel—head and neck cancer	0.00416	0.00416	CcSEcCtD
Sibutramine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00414	0.00414	CcSEcCtD
Sibutramine—Fluid retention—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Sibutramine—Ataxia—Fluorouracil—head and neck cancer	0.0041	0.0041	CcSEcCtD
Sibutramine—Alopecia—Vinblastine—head and neck cancer	0.00406	0.00406	CcSEcCtD
Sibutramine—Dry skin—Fluorouracil—head and neck cancer	0.00399	0.00399	CcSEcCtD
Sibutramine—Oesophagitis—Docetaxel—head and neck cancer	0.00396	0.00396	CcSEcCtD
Sibutramine—Neoplasm—Docetaxel—head and neck cancer	0.00392	0.00392	CcSEcCtD
Sibutramine—Muscular weakness—Fluorouracil—head and neck cancer	0.00384	0.00384	CcSEcCtD
Sibutramine—Angiopathy—Hydroxyurea—head and neck cancer	0.0038	0.0038	CcSEcCtD
Sibutramine—Dysphagia—Fluorouracil—head and neck cancer	0.00376	0.00376	CcSEcCtD
Sibutramine—Sepsis—Docetaxel—head and neck cancer	0.00376	0.00376	CcSEcCtD
Sibutramine—Chills—Hydroxyurea—head and neck cancer	0.00376	0.00376	CcSEcCtD
Sibutramine—Eosinophilia—Fluorouracil—head and neck cancer	0.00373	0.00373	CcSEcCtD
Sibutramine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00371	0.00371	CcSEcCtD
Sibutramine—Alopecia—Hydroxyurea—head and neck cancer	0.0037	0.0037	CcSEcCtD
Sibutramine—Anaemia—Vinblastine—head and neck cancer	0.00369	0.00369	CcSEcCtD
Sibutramine—Angina pectoris—Fluorouracil—head and neck cancer	0.00367	0.00367	CcSEcCtD
Sibutramine—Phlebitis—Docetaxel—head and neck cancer	0.00365	0.00365	CcSEcCtD
Sibutramine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
Sibutramine—Malaise—Vinblastine—head and neck cancer	0.0036	0.0036	CcSEcCtD
Sibutramine—Vertigo—Vinblastine—head and neck cancer	0.00359	0.00359	CcSEcCtD
Sibutramine—Leukopenia—Vinblastine—head and neck cancer	0.00358	0.00358	CcSEcCtD
Sibutramine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00347	0.00347	CcSEcCtD
Sibutramine—Convulsion—Vinblastine—head and neck cancer	0.00346	0.00346	CcSEcCtD
Sibutramine—Hypertension—Vinblastine—head and neck cancer	0.00345	0.00345	CcSEcCtD
Sibutramine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00344	0.00344	CcSEcCtD
Sibutramine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00338	0.00338	CcSEcCtD
Sibutramine—Pneumonia—Fluorouracil—head and neck cancer	0.00338	0.00338	CcSEcCtD
Sibutramine—Anaemia—Hydroxyurea—head and neck cancer	0.00337	0.00337	CcSEcCtD
Sibutramine—Discomfort—Vinblastine—head and neck cancer	0.00336	0.00336	CcSEcCtD
Sibutramine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00332	0.00332	CcSEcCtD
Sibutramine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00331	0.00331	CcSEcCtD
Sibutramine—Renal impairment—Docetaxel—head and neck cancer	0.0033	0.0033	CcSEcCtD
Sibutramine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00329	0.00329	CcSEcCtD
Sibutramine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00329	0.00329	CcSEcCtD
Sibutramine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00329	0.00329	CcSEcCtD
Sibutramine—Malaise—Hydroxyurea—head and neck cancer	0.00329	0.00329	CcSEcCtD
Sibutramine—Stomatitis—Fluorouracil—head and neck cancer	0.00327	0.00327	CcSEcCtD
Sibutramine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00326	0.00326	CcSEcCtD
Sibutramine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00326	0.00326	CcSEcCtD
Sibutramine—Leukopenia—Hydroxyurea—head and neck cancer	0.00326	0.00326	CcSEcCtD
Sibutramine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00319	0.00319	CcSEcCtD
Sibutramine—Epistaxis—Fluorouracil—head and neck cancer	0.00317	0.00317	CcSEcCtD
Sibutramine—Convulsion—Hydroxyurea—head and neck cancer	0.00316	0.00316	CcSEcCtD
Sibutramine—Sinusitis—Fluorouracil—head and neck cancer	0.00315	0.00315	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00314	0.00314	CcSEcCtD
Sibutramine—Pain in extremity—Docetaxel—head and neck cancer	0.00314	0.00314	CcSEcCtD
Sibutramine—Anorexia—Vinblastine—head and neck cancer	0.00311	0.00311	CcSEcCtD
Sibutramine—Migraine—Docetaxel—head and neck cancer	0.00309	0.00309	CcSEcCtD
Sibutramine—Discomfort—Hydroxyurea—head and neck cancer	0.00307	0.00307	CcSEcCtD
Sibutramine—Haemoglobin—Fluorouracil—head and neck cancer	0.00303	0.00303	CcSEcCtD
Sibutramine—Rhinitis—Fluorouracil—head and neck cancer	0.00302	0.00302	CcSEcCtD
Sibutramine—Haemorrhage—Fluorouracil—head and neck cancer	0.00301	0.00301	CcSEcCtD
Sibutramine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.003	0.003	CcSEcCtD
Sibutramine—Pharyngitis—Fluorouracil—head and neck cancer	0.00299	0.00299	CcSEcCtD
Sibutramine—Oedema—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Sibutramine—Ataxia—Docetaxel—head and neck cancer	0.00296	0.00296	CcSEcCtD
Sibutramine—Infection—Hydroxyurea—head and neck cancer	0.00295	0.00295	CcSEcCtD
Sibutramine—Paraesthesia—Vinblastine—head and neck cancer	0.00293	0.00293	CcSEcCtD
Sibutramine—Dehydration—Docetaxel—head and neck cancer	0.00292	0.00292	CcSEcCtD
Sibutramine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00291	0.00291	CcSEcCtD
Sibutramine—Liver function test abnormal—Docetaxel—head and neck cancer	0.0029	0.0029	CcSEcCtD
Sibutramine—Skin disorder—Hydroxyurea—head and neck cancer	0.00289	0.00289	CcSEcCtD
Sibutramine—Dry skin—Docetaxel—head and neck cancer	0.00288	0.00288	CcSEcCtD
Sibutramine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00287	0.00287	CcSEcCtD
Sibutramine—Anorexia—Hydroxyurea—head and neck cancer	0.00284	0.00284	CcSEcCtD
Sibutramine—Decreased appetite—Vinblastine—head and neck cancer	0.00284	0.00284	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00283	0.00283	CcSEcCtD
Sibutramine—Constipation—Vinblastine—head and neck cancer	0.00279	0.00279	CcSEcCtD
Sibutramine—Pain—Vinblastine—head and neck cancer	0.00279	0.00279	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00277	0.00277	CcSEcCtD
Sibutramine—Dysphagia—Docetaxel—head and neck cancer	0.00272	0.00272	CcSEcCtD
Sibutramine—Arrhythmia—Fluorouracil—head and neck cancer	0.00269	0.00269	CcSEcCtD
Sibutramine—Feeling abnormal—Vinblastine—head and neck cancer	0.00269	0.00269	CcSEcCtD
Sibutramine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00267	0.00267	CcSEcCtD
Sibutramine—Alopecia—Fluorouracil—head and neck cancer	0.00266	0.00266	CcSEcCtD
Sibutramine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00265	0.00265	CcSEcCtD
Sibutramine—Angina pectoris—Docetaxel—head and neck cancer	0.00265	0.00265	CcSEcCtD
Sibutramine—Somnolence—Hydroxyurea—head and neck cancer	0.00264	0.00264	CcSEcCtD
Sibutramine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00262	0.00262	CcSEcCtD
Sibutramine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00259	0.00259	CcSEcCtD
Sibutramine—Abdominal pain—Vinblastine—head and neck cancer	0.00258	0.00258	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00257	0.00257	CcSEcCtD
Sibutramine—Constipation—Hydroxyurea—head and neck cancer	0.00254	0.00254	CcSEcCtD
Sibutramine—Pain—Hydroxyurea—head and neck cancer	0.00254	0.00254	CcSEcCtD
Sibutramine—Weight increased—Docetaxel—head and neck cancer	0.00247	0.00247	CcSEcCtD
Sibutramine—Vision blurred—Fluorouracil—head and neck cancer	0.00247	0.00247	CcSEcCtD
Sibutramine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00245	0.00245	CcSEcCtD
Sibutramine—Pneumonia—Docetaxel—head and neck cancer	0.00244	0.00244	CcSEcCtD
Sibutramine—Anaemia—Fluorouracil—head and neck cancer	0.00242	0.00242	CcSEcCtD
Sibutramine—Hypersensitivity—Vinblastine—head and neck cancer	0.0024	0.0024	CcSEcCtD
Sibutramine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00239	0.00239	CcSEcCtD
Sibutramine—Renal failure—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Sibutramine—Myocardial infarction—Docetaxel—head and neck cancer	0.00237	0.00237	CcSEcCtD
Sibutramine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00237	0.00237	CcSEcCtD
Sibutramine—Stomatitis—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Sibutramine—Conjunctivitis—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Sibutramine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00235	0.00235	CcSEcCtD
Sibutramine—Leukopenia—Fluorouracil—head and neck cancer	0.00235	0.00235	CcSEcCtD
Sibutramine—Asthenia—Vinblastine—head and neck cancer	0.00234	0.00234	CcSEcCtD
Sibutramine—Epistaxis—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Sibutramine—Convulsion—Fluorouracil—head and neck cancer	0.00227	0.00227	CcSEcCtD
Sibutramine—Chest pain—Fluorouracil—head and neck cancer	0.00223	0.00223	CcSEcCtD
Sibutramine—Myalgia—Fluorouracil—head and neck cancer	0.00223	0.00223	CcSEcCtD
Sibutramine—Diarrhoea—Vinblastine—head and neck cancer	0.00223	0.00223	CcSEcCtD
Sibutramine—Discomfort—Fluorouracil—head and neck cancer	0.00221	0.00221	CcSEcCtD
Sibutramine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00219	0.00219	CcSEcCtD
Sibutramine—Haemoglobin—Docetaxel—head and neck cancer	0.00219	0.00219	CcSEcCtD
Sibutramine—Rhinitis—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Sibutramine—Haemorrhage—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Sibutramine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00216	0.00216	CcSEcCtD
Sibutramine—Confusional state—Fluorouracil—head and neck cancer	0.00216	0.00216	CcSEcCtD
Sibutramine—Pharyngitis—Docetaxel—head and neck cancer	0.00216	0.00216	CcSEcCtD
Sibutramine—Dizziness—Vinblastine—head and neck cancer	0.00216	0.00216	CcSEcCtD
Sibutramine—Oedema peripheral—Docetaxel—head and neck cancer	0.00214	0.00214	CcSEcCtD
Sibutramine—Oedema—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Sibutramine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Sibutramine—Asthenia—Hydroxyurea—head and neck cancer	0.00213	0.00213	CcSEcCtD
Sibutramine—Infection—Fluorouracil—head and neck cancer	0.00213	0.00213	CcSEcCtD
Sibutramine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0021	0.0021	CcSEcCtD
Sibutramine—Visual impairment—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Sibutramine—Tachycardia—Fluorouracil—head and neck cancer	0.00209	0.00209	CcSEcCtD
Sibutramine—Vomiting—Vinblastine—head and neck cancer	0.00207	0.00207	CcSEcCtD
Sibutramine—Headache—Vinblastine—head and neck cancer	0.00204	0.00204	CcSEcCtD
Sibutramine—Anorexia—Fluorouracil—head and neck cancer	0.00204	0.00204	CcSEcCtD
Sibutramine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00204	0.00204	CcSEcCtD
Sibutramine—Eye disorder—Docetaxel—head and neck cancer	0.00203	0.00203	CcSEcCtD
Sibutramine—Hypotension—Fluorouracil—head and neck cancer	0.002	0.002	CcSEcCtD
Sibutramine—Angiopathy—Docetaxel—head and neck cancer	0.00197	0.00197	CcSEcCtD
Sibutramine—Dizziness—Hydroxyurea—head and neck cancer	0.00197	0.00197	CcSEcCtD
Sibutramine—Immune system disorder—Docetaxel—head and neck cancer	0.00196	0.00196	CcSEcCtD
Sibutramine—Chills—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00195	0.00195	CcSEcCtD
Sibutramine—Arrhythmia—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Sibutramine—Nausea—Vinblastine—head and neck cancer	0.00194	0.00194	CcSEcCtD
Sibutramine—Insomnia—Fluorouracil—head and neck cancer	0.00194	0.00194	CcSEcCtD
Sibutramine—Paraesthesia—Fluorouracil—head and neck cancer	0.00192	0.00192	CcSEcCtD
Sibutramine—Alopecia—Docetaxel—head and neck cancer	0.00192	0.00192	CcSEcCtD
Sibutramine—Dyspnoea—Fluorouracil—head and neck cancer	0.00191	0.00191	CcSEcCtD
Sibutramine—Somnolence—Fluorouracil—head and neck cancer	0.0019	0.0019	CcSEcCtD
Sibutramine—Malnutrition—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Sibutramine—Vomiting—Hydroxyurea—head and neck cancer	0.00189	0.00189	CcSEcCtD
Sibutramine—Dyspepsia—Fluorouracil—head and neck cancer	0.00188	0.00188	CcSEcCtD
Sibutramine—Rash—Hydroxyurea—head and neck cancer	0.00188	0.00188	CcSEcCtD
Sibutramine—Dermatitis—Hydroxyurea—head and neck cancer	0.00187	0.00187	CcSEcCtD
Sibutramine—Headache—Hydroxyurea—head and neck cancer	0.00186	0.00186	CcSEcCtD
Sibutramine—Decreased appetite—Fluorouracil—head and neck cancer	0.00186	0.00186	CcSEcCtD
Sibutramine—Dysgeusia—Docetaxel—head and neck cancer	0.00185	0.00185	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00185	0.00185	CcSEcCtD
Sibutramine—Back pain—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Sibutramine—Pain—Fluorouracil—head and neck cancer	0.00183	0.00183	CcSEcCtD
Sibutramine—Muscle spasms—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Sibutramine—Nausea—Hydroxyurea—head and neck cancer	0.00177	0.00177	CcSEcCtD
Sibutramine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00176	0.00176	CcSEcCtD
Sibutramine—Anaemia—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Sibutramine—Urticaria—Fluorouracil—head and neck cancer	0.0017	0.0017	CcSEcCtD
Sibutramine—Syncope—Docetaxel—head and neck cancer	0.0017	0.0017	CcSEcCtD
Sibutramine—Leukopenia—Docetaxel—head and neck cancer	0.00169	0.00169	CcSEcCtD
Sibutramine—Body temperature increased—Fluorouracil—head and neck cancer	0.00169	0.00169	CcSEcCtD
Sibutramine—Palpitations—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Sibutramine—Loss of consciousness—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Sibutramine—Cough—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
Sibutramine—Convulsion—Docetaxel—head and neck cancer	0.00164	0.00164	CcSEcCtD
Sibutramine—Hypertension—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Sibutramine—Arthralgia—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Sibutramine—Chest pain—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Sibutramine—Myalgia—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Sibutramine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00158	0.00158	CcSEcCtD
Sibutramine—Dry mouth—Docetaxel—head and neck cancer	0.00158	0.00158	CcSEcCtD
Sibutramine—Confusional state—Docetaxel—head and neck cancer	0.00156	0.00156	CcSEcCtD
Sibutramine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Sibutramine—Oedema—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Sibutramine—Infection—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Sibutramine—Shock—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Sibutramine—Pruritus—Fluorouracil—head and neck cancer	0.00151	0.00151	CcSEcCtD
Sibutramine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00151	0.00151	CcSEcCtD
Sibutramine—Tachycardia—Docetaxel—head and neck cancer	0.00151	0.00151	CcSEcCtD
Sibutramine—Skin disorder—Docetaxel—head and neck cancer	0.0015	0.0015	CcSEcCtD
Sibutramine—Anorexia—Docetaxel—head and neck cancer	0.00147	0.00147	CcSEcCtD
Sibutramine—Diarrhoea—Fluorouracil—head and neck cancer	0.00146	0.00146	CcSEcCtD
Sibutramine—Hypotension—Docetaxel—head and neck cancer	0.00144	0.00144	CcSEcCtD
Sibutramine—Dizziness—Fluorouracil—head and neck cancer	0.00142	0.00142	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00141	0.00141	CcSEcCtD
Sibutramine—Insomnia—Docetaxel—head and neck cancer	0.0014	0.0014	CcSEcCtD
Sibutramine—Paraesthesia—Docetaxel—head and neck cancer	0.00139	0.00139	CcSEcCtD
Sibutramine—Dyspnoea—Docetaxel—head and neck cancer	0.00138	0.00138	CcSEcCtD
Sibutramine—Somnolence—Docetaxel—head and neck cancer	0.00137	0.00137	CcSEcCtD
Sibutramine—Vomiting—Fluorouracil—head and neck cancer	0.00136	0.00136	CcSEcCtD
Sibutramine—Dyspepsia—Docetaxel—head and neck cancer	0.00136	0.00136	CcSEcCtD
Sibutramine—Rash—Fluorouracil—head and neck cancer	0.00135	0.00135	CcSEcCtD
Sibutramine—Dermatitis—Fluorouracil—head and neck cancer	0.00135	0.00135	CcSEcCtD
Sibutramine—Decreased appetite—Docetaxel—head and neck cancer	0.00134	0.00134	CcSEcCtD
Sibutramine—Headache—Fluorouracil—head and neck cancer	0.00134	0.00134	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00133	0.00133	CcSEcCtD
Sibutramine—Pain—Docetaxel—head and neck cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Constipation—Docetaxel—head and neck cancer	0.00132	0.00132	CcSEcCtD
Sibutramine—Feeling abnormal—Docetaxel—head and neck cancer	0.00127	0.00127	CcSEcCtD
Sibutramine—Nausea—Fluorouracil—head and neck cancer	0.00127	0.00127	CcSEcCtD
Sibutramine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00126	0.00126	CcSEcCtD
Sibutramine—Abdominal pain—Docetaxel—head and neck cancer	0.00122	0.00122	CcSEcCtD
Sibutramine—Body temperature increased—Docetaxel—head and neck cancer	0.00122	0.00122	CcSEcCtD
Sibutramine—Hypersensitivity—Docetaxel—head and neck cancer	0.00114	0.00114	CcSEcCtD
Sibutramine—Asthenia—Docetaxel—head and neck cancer	0.00111	0.00111	CcSEcCtD
Sibutramine—Pruritus—Docetaxel—head and neck cancer	0.00109	0.00109	CcSEcCtD
Sibutramine—Diarrhoea—Docetaxel—head and neck cancer	0.00106	0.00106	CcSEcCtD
Sibutramine—Dizziness—Docetaxel—head and neck cancer	0.00102	0.00102	CcSEcCtD
Sibutramine—Vomiting—Docetaxel—head and neck cancer	0.000983	0.000983	CcSEcCtD
Sibutramine—Rash—Docetaxel—head and neck cancer	0.000974	0.000974	CcSEcCtD
Sibutramine—Dermatitis—Docetaxel—head and neck cancer	0.000973	0.000973	CcSEcCtD
Sibutramine—Headache—Docetaxel—head and neck cancer	0.000968	0.000968	CcSEcCtD
Sibutramine—Nausea—Docetaxel—head and neck cancer	0.000918	0.000918	CcSEcCtD
